0001127602-18-028076.txt : 20180919 0001127602-18-028076.hdr.sgml : 20180919 20180919170038 ACCESSION NUMBER: 0001127602-18-028076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180917 FILED AS OF DATE: 20180919 DATE AS OF CHANGE: 20180919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANADILLO PEDRO P CENTRAL INDEX KEY: 0001217544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 181078131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-09-17 0000313143 HAEMONETICS CORP HAE 0001217544 GRANADILLO PEDRO P 400 WOOD ROAD BRAINTREE MA 02184 1 Common Stock 2018-09-17 4 M 0 8196 36.37 A 41555 D Common Stock 2018-09-17 4 M 0 6573 45.45 A 48128 D Common Stock 2018-09-17 4 M 0 10353 35.50 A 58481 D Common Stock 2018-09-17 4 S 0 1502 108.92 D 56979 D Common Stock 2018-09-17 4 S 0 3696 110.11 D 53283 D Common Stock 2018-09-17 4 S 0 13183 111.33 D 40100 D Common Stock 2018-09-17 4 S 0 11812 113.16 D 28288 D Common Stock 2018-09-17 4 S 0 631 114.16 D 27657 D Non-qualified Stock Option (Right to Buy) 36.37 2018-09-17 4 M 0 8196 0 D 2013-07-27 2019-07-27 Common Stock 8196 0 D Non-qualified Stock Option (Right to Buy) 45.45 2018-09-17 4 M 0 6573 0 D 2014-07-24 2020-07-24 Common Stock 6573 0 D Non-qualified Stock Option (Right to Buy) 35.50 2018-09-17 4 M 0 10353 0 D 2015-07-23 2021-07-23 Common Stock 10353 0 D Transaction pursuant to an existing 10b5-1 trading plan. This number includes unvested restricted stock units previously reported. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.61 to $109.33, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.79 to $110.55, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.92 to 111.88, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.51 to $113.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114 to $114.44, inclusive. Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Mr. Granadillo 2018-09-19